Trial intelligence / Profile preview

Observing Platelet Activability in a Once Daily vs. More Frequent Aspirin Regimen

2014-002928-27Phase 4Active

Sponsor
VU university medical center
Start
Feb 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of aspirin in cardiac morbidity (2 arms), sponsored by VU university medical center. Primary endpoint: PFA-200 parameters. Started Feb 2015; status: active.

02

Drugs

aspirin
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on 2014-002928-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002928-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call